UPDATE 1-Roche to pay $2.4 bln to buy rest of Foundation Medicine

ZURICH, June 19 (Reuters) - Swiss drugmaker Roche Holding AG has agreed to pay $137 per share to buy the rest of Foundation Medicine (FMI), a $2.4 billion transaction that values the U.S. genomic profiling group at $5.3 billion, the partners said on Tuesday.